Certara

About Certara

Certara is a CRO / Clinical Trials company; the kind of vendor BD teams should have a 15-minute conversation with at SNMMI.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Endpoints News · 2026-04-17
  Certara signs supply agreement to support late-stage trials
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
• Reuters Health · 2026-07-10
  Certara appoints new Chief Medical Officer ahead of pivotal trial
  Coverage notes the company's growing footprint in the radioligand therapy space.
• BioPharma Reporter · 2026-10-27
  Certara announces Phase II readout for lead theranostic candidate
  The work builds on more than a decade of radiochemistry collaboration.
• FierceBiotech · 2026-01-24
  Certara expands cyclotron capacity to meet Lu-177 demand
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• STAT News · 2026-04-05
  Certara partners with academic center on Actinium-225 program
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.